Medical oncologist Jia Li

Jia Li, MD, PhD

Gastrointestinal Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Gastrointestinal cancers and conditions
  • Colon cancer
  • Rectal cancer

My Specialties

  • Early-phase clinical trials
View more expertise
Dr. Li's Office Information
Languages: English & Mandarin
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist who specializes in caring for people with gastrointestinal cancers. These include colorectal cancer, hepatobiliary cancer, esophageal cancer, stomach cancer, and pancreatic cancer.

I see patients at Memorial Sloan Kettering Commack. I feel privileged to provide state-of-the-art care to our patients close to home on Long Island.

 

As a member of MSK’s Gastrointestinal Oncology Service, I am part of a team of experts from different areas. My colleagues include medical oncologists, surgical oncologists, radiation oncologists, radiologists, psychiatrists, oncology nurses, social workers, and dieticians. 

We provide our patients with the highest-quality care. We also offer access to many cancer clinical trials at MSK Commack and help patients enroll in studies based at MSK in Manhattan. 

My research has focused on developing new therapies for gastrointestinal cancers. I am currently a lead and co-lead author for several early-phase trials for pancreatic cancer, gastric cancer, and esophageal cancer. I also have written several book chapters on cancer care.

What I Do at MSK

I'm a gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist, which is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers. We also treat GI stromal tumors and neuroendocrine tumors.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Gastrointestinal cancers and conditions
  • Colon cancer
  • Rectal cancer
  • Esophageal cancers and conditions
  • Stomach (gastric) cancer
  • Pancreatic cancer

My Specialties

  • Early-phase clinical trials
Education & Honors

Education

  • MD, Tianjin Medical University

Residencies

  • Internal Medicine - Albert Einstein College of Medicine

Fellowships

  • Medical Oncology/Hematology - Yale Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology and Hematology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9053— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
Commack, NY
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
650 Commack Road Commack NY 11725
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Gastrointestinal Oncology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Peer-Reviewed Articles

Li J, Kluger H, Lesley D, et al. Phase I Study of Safety and Tolerability of Sunitinib in Combination with Sirolimus in Patients with Refractory Solid Malignancies and Determination of VEGF (VEGF A) and soluble VEGF-R2 (sVEGFR2) in plasma. Cancer Chemotherapy and Pharmacology. 2016, Apr 21 [Epub ahead of print]

Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, et al. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Br J Cancer. 2016;114(7):809-12.

Li J, Yao X, Kortmansky JS, et al. Phase II study of modified FOLFOX6 with bevacizumab in metastatic gastroesophageal adenocarcinoma. AJCO. 2014 Aug 20 (Epub ahead of print).

Saif MW, Li J, Lamb L, et al. First-in-human Phase II Trial of the Botanical Formulation PHY906 with Capecitabine as Second-line Therapy in Patients with Advanced Pancreatic Cancer. Cancer Chemother Pharmacol. 2014;73(2):373-380

Zhang X, Li J. Era of universal testing of microsatellite instability in colorectal cancer. World J Gastrointest Oncol. 2013;5(2):12-9.

Li J, Merl MY, Lee MX, et al. Safety and efficacy of single day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience. Expert Opinion on Drug Safety. 2010;9(2):207-13.

Li J, Saif MW. Current use and potential role of bevacizumab in gastrointestinal cancers. Biologics: Target & Therapy 2009;3:429-441.

Li J, Podoltsev N, Saif MW. Management of advanced pancreatic cancer. Expert Review of Clinical Pharmacology 2009:2(5):527-541.​

Publications on PubMed

Visit PubMed for a full listing of Dr. Li’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Jia Li discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: